Findoc-cll.in/2nd_qtr_result

COLINZ LABORATORIES LIMITED
A-101, Pratik Ind. Estate, Next to Fortis Hospital, Mulund-Goregaon Link Road, Mumbai - 400 078.

UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH SEPTEMBER 2012

							(Rupees in '000')
S. No.	Particulars		Un -audited			Un-audited		Audited
			Quarter Ended			Half Year Ended		Year
			30.09.2012	30.06.2012	30.09.2011	30.09.2012	30.09.2011	31.03.2012
PART-l	(a)Income from Operation
1	Gross Sales		19,157	23,253	17,762	42,410	39,734	70,455
	less Excise Duty		1,264	1,547	1,130	2,811	1927	4,435
	Net Sales/Income From Operation		17,893	21,706	16,632	39,599	37,807	66,020
	(b) Other Operating Income		-	-	-	-	-	-
	Total Income from Operation		17,893	21,706	16,632	39,599	37,807	66,020
2	Expenses
	(a)	Cost Of Material Consumed	7,088	5,984	6,833	13,072	13,070	24,418
	(b)	Purchase of Stock in Trade	1,504	1,870	1,349	3,374	2,037	3,457
	(c)	Change in Inventories Of Finished Goods and Work in Progress of Stock in trade	(2,224)	2,389	(1,974)	165	2,453	(1,095)
	(d)	Employee Benefit Expenses	6,592	6,881	6,178	13,473	11,619	22,545
	(e)	Depreciation & Amortisation Expenses	653	653	644	1,306	1,289	2,599
	(f)	Other Expenses	3,509	3,112	3,052	6,621	6,089	11,694
	Total Expenses		17,122	20,889	16,082	38,011	36,557	63,618
3	Profit/(Loss) from Operation Before Other Income ( 1-2)		771	817	550	1,588	1,250	2,402
4	Other Income		248	206	126	454	154	369
5	Profit /(Loss) from ordinary activities before		1,019	1,023	676	2,042	1,404	2,771
	finance cost & Exception items ( 3+4)
6	Finance Cost		542	537	388	1,079	797	1,893
7	Profit /(Loss) from ordinary activities after finance Cost but before Exceptional items ( 5-6)		477	486	288	963	607	878
8	Exceptional items		-	-		-	-	-
9	Profit /(Loss) from ordinary activities before Tax ( 7-8)		477	486	288	963	607	878
10	Tax Expenses ( Provision for Taxation ) Current tax Deffered tax		0	0	0	0	0	158
			0	0	0	0	0	(384)
11	Net Profit/(Loss) From Ordinary Activities after Tax (9-10)		477	486	288	963	607	1,104
12	Paid up Equity Share Capital ( Face Value 10/- Per Share ) [Net of allotment money in arrears]		354,35	354,35	354,35	354,35	354,35	354,35
13	Reserves Excluding Revaluation Reserves		-	-	-	-	-	7,630
14	Earning per share (EPS) before extraordinary item( not Annualised)		-	-	-	-	-	-
	i) Basic & Diluted		-	-	-	-	0	0.24
	ii) Diluted		-	-	-	-	-	-
PART-ll	PARTICULARS OF SHAREHOLDING
1	Public shareholding
	i	Number of Shares	2,904,901	2,904,900	3,080,150	2,904,901	3,080,150	2,902,900
	ii	Percentage of shareholding	63.55%	63.55%	67.38%	63.55%	67.38%	63.51%
2	Promoters and promoter group Shareholding
	a)	Pledged/Encumbered
	i	Number of shares
	ii	Percentage of shares (as a % of the total shareholding of promoter and promoter group)
	iii	Percentage of shares (as a% of the total share capital of the company)
	b)	Non-encumbered
	-	Number of Shares	1,666,099	1,666,100	1,490,850	1,666,099	1,490,850	1,668,100
	-	Percentage of shares (as a% of the total shareholding of promoter and promoter group)	36.45%	36.45%	32.62%	36.45%	32.62%	36.49%
	Percentage of shares (as a % of the total share capital of the company)		100%	100%	100%	100%	100%	100%
B	INVESTORS COMPLAINTS					3 MONTHS ENDED 30-9-2012
	Pending at Begining of the Quarter						NIL
	Received During the Quarter						NIL
	Disposed of During the Quarter						NIL
	Remaining at the end of the Quarter						NIL

(Rupees in ‘ 000)

STATEMENT OF ASSETS AND LIABILITES
		PARTICULARS	30.09.2012 (Un-Audited)	31.03.2012 (Audited)
A		CAPITAL & LIABILITIES
1		Shareholders Funds
	a)	Share Capital	35,435	35,435
	b)	Reserve and Surplus	27,313	26,345
		Total	62,748	61,780
2		NON CURRENT LIABILITIES
	a)	Long term borrowing	26,126	23,918
	b)	Deffered tax liability( net)	3,100	3,100
	c)	Other long term liability	116	98
	d)	Long term Provision	-	-
		Total	29,342	27,116
3		CURRENT LIABILITIES
	a)	Short term borrowing	-	-
	b)	Trade payable	8,027	9,126
	c)	Other current liabilities	5,893	4,147
	d)	Short term provision	-	-
		Total	13,920	13,273

		Total (1+2+3)	106,010	102,169
B		ASSETS
1		NON CURRENT ASSETS
	a)	Fixed Assets	41,073	42,361
	b)	Non current investments	3,159	3,159
	c)	Long terms loan and advance	13,544	13,763
	d)	Other Non current assets	6,530	4,289
		Total	64,306	63,572
		CURRENT ASSETS
2	a)	Inventries	21,337	21,333
	b)	Trade receivable	16,150	10,843
	c)	Cash and cash equivalents	3,307	5,494
	d)	Short term loan and advances	910	927
		Total	41,704	38,597

		Total (1+2)	106,010	102,169

NOTES :-

The above financial results have been taken on record at a meeting of Board of Directors held on 31-10-2012
The Company operates in single segment of manufacture of pharmaceutical formulations. Hence Accounting Standard on segment reporting is not applicable.
Previous period figures have been regrouped wherever required.